section name header

Evidence summaries

Benzodiazepines for Generalized Anxiety Disorder

Benzodiazepines are more effective than placebo for symptom reduction in generalized anxiety disorder, but they cause clinically significant adverse effects. Level of evidence: "A"

A topic in Clinical Evidence 1 summarizes the results of one systematic review (search date 1996) including 17 RCTs with a total of 2044 people and 1 subsequent RCT. The systematic review found that benzodiazepines significantly improved symptoms over 2-9 weeks (effect size 0.70, CI not reported) compared to placebo. The subsequent RCT (n=310, comparing 3 interventions) reported response in 73% of patients on diazepam compared to 56% of patients on placebo, p<0.01). RCTs and observational studies found that benzodiazepines increased the risk of dependence, sedation, industrial accidents, and road traffic accidents. Clinical evidence category: Trade off between benefit and harm.

References

  • Gale C, Oakley-Browne M. What are the effects of treatments. Generalized anxiety disorder. Clinical Evidence 2005;13:1279-1290.

Primary/Secondary Keywords